Xenon Pharmaceuticals Inc. - Common Shares (XENE)

♥ 539 Thanks from members

Web sentiment and market data for Xenon Pharmaceuticals Inc. Common Shares (XENE) indicate recent minor downward price movement to $62.32, alongside standard disclosures regarding high-degree market risks, interest rate exposures, and currency fluctuations.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Healthcare Industry: Biotechnology Founder: InviCRO / Scientific Founders Leadership: Ian Mortimer (CEO) Leadership: Christopher Kenney (CMO) Holder: Fidelity Management & Research Holder: BlackRock Inc. Holder: RA Capital Management Azetukalner (XEN1101) XEN496 Neurology Pipeline #Xenon Pharmaceuticals #XENE #neuroscience biotech #epilepsy treatment #clinical-stage pharma